HomeInsightsStock Comparison

Mono Pharmacare Ltd vs Piramal Pharma Ltd Stock Comparison

Mono Pharmacare Ltd vs Piramal Pharma Ltd Stock Comparison

Last Updated on: Jun 22, 2025

Key Highlights

  • The Latest Trading Price of Mono Pharmacare Ltd is ₹ 24.45 as of 20 Jun 15:30.
  • The P/E Ratio of Mono Pharmacare Ltd changed from 32 on March 2024 to 32 on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Piramal Pharma Ltd changed from 991.5 on March 2024 to 991.5 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Mono Pharmacare Ltd changed from ₹ 77.92 crore on March 2024 to ₹ 77.92 crore on March 2024 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Piramal Pharma Ltd changed from ₹ 8165 crore on March 2023 to ₹ 17052 crore on March 2024 . This represents a CAGR of 44.51% over 2 years.
  • The revenue of Mono Pharmacare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Piramal Pharma Ltd for the Mar '25 is ₹ 2812 crore as compare to the Dec '24 revenue of ₹ 2233 crore. This represent the growth of 25.92%.
  • The ebitda of Mono Pharmacare Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Piramal Pharma Ltd for the Mar '25 is ₹ 619.24 crore as compare to the Dec '24 ebitda of ₹ 366.92 crore. This represent the growth of 68.77%.
  • The net profit of Mono Pharmacare Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Piramal Pharma Ltd changed from ₹ -98.58 crore to ₹ 153.5 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Mono Pharmacare Ltd changed from 0 % on March 2021 to 0 % on March 2024 . This represents a CAGR of 0.0% over 4 yearsThe Dividend Payout of Piramal Pharma Ltd changed from 18.07 % on March 2022 to 3.72 % on March 2024 . This represents a CAGR of -40.95% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Mono Pharmacare Ltd

  • Mono Pharmacare Limited was originally formed as a Partnership Firm in the name and style of 'M/s.
  • Mono Chemist' through Partnership Deed dated May 06, 1994.
  • The Partnership Firm was then converted into Public Limited company in the name of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad.
  • The Company is engaged in the business of marketing and distribution of pharmaceutical products. The product portfolio comprises of a wide range of drugs like Antibiotics, Antifungal, Anti CoughCold & Anti-allergic, Antacid and Antiemetics, Analgesics and Antipyretics, Nutraceuticals, Skincare, Antiseptic, Cardiac and Diabetic & Cosmetics etc. getting products manufactured through contract manufacturing. Supal Distributors LLP, a Partnership Firm, was incorporated on November 24, 2016, with the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya, being the Original Partners.

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. PPL is a leading pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.
  • It operate under three business verticals - Piramal Pharma Solutions, an integrated contract development and manufacturing organization (CDMO) having a product suite in niche areas such as highly potent Active pharmaceutical ingredients (APIs), Finished dosage forms (FDFs), antibody drug conjugates, potent sterile injectable, hormonal oral solid dosage forms, biologics and vaccines; Piramal Critical Care, a complex hospital generics (CHG) business in the areas of inhalation anaesthesia, injectable anaesthesia and pain management, intrathecal therapy and other injectable; and India consumer healthcare (ICH) business, selling well-known OTC brands.

Mono Pharmacare Ltd News Hub

News

Mono Pharmacare to conduct board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 28 May 202...

Read more

13 May 2025 16:38

News

Mono Pharmacare announces board meeting date

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 11 April 2...

Read more

05 Apr 2025 14:35

News

Mono Pharmacare to hold board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 2 April 20...

Read more

29 Mar 2025 09:47

News

Mono Pharmacare to convene board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 10 Februar...

Read more

03 Feb 2025 10:50

News

Mono Pharmacare announces board meeting date

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 11 January...

Read more

04 Jan 2025 10:27

News

Mono Pharmacare to convene board meeting

Mono Pharmacare will hold a meeting of the Board of Directors of the Company on 14 Novembe...

Read more

07 Nov 2024 15:32

Piramal Pharma Ltd News Hub

News

Piramal Pharma to conduct AGM

Piramal Pharma announced that the 5th Annual General Meeting(AGM) of the company will be h...

Read more

14 Jun 2025 14:54

News

Piramal Pharma's Aurora unit completes USFDA inspection

Piramal Pharma announced that the US FDA conducted a general GMP (Good Manufacturing Pract...

Read more

02 Jun 2025 16:21

News

Piramal Pharma's Canada facility gets zero USFDA observation

According to a regulatory filing, the inspection was carried out from 26 May 2025 to 30 Ma...

Read more

02 Jun 2025 11:16

News

Piramal Pharma allots 35 lakh equity shares under ESOP

Piramal Pharma has allotted 35 lakh equity shares under ESOP on 21 May 2025. Consequent to...

Read more

21 May 2025 15:37

News

Board of Piramal Pharma recommends final dividend

Piramal Pharma announced that the Board of Directors of the Company at its meeting held on...

Read more

15 May 2025 10:18

News

Piramal Pharma's Turbhe facility successfully completes USFDA inspection

Piramal Pharma announced that the USFDA has issued an Establishment Inspection Report (EIR...

Read more

12 May 2025 12:47

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Mono Pharmacare Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Mono Pharmacare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Mono Pharmacare Ltd and Piramal Pharma Ltd

Which company has a larger market capitalization, Mono Pharmacare Ltd or Piramal Pharma Ltd?

Market cap of Mono Pharmacare Ltd is 43 Cr while Market cap of Piramal Pharma Ltd is 25,926 Cr

What are the key factors driving the stock performance of Mono Pharmacare Ltd and Piramal Pharma Ltd?

The stock performance of Mono Pharmacare Ltd and Piramal Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Mono Pharmacare Ltd and Piramal Pharma Ltd?

As of June 22, 2025, the Mono Pharmacare Ltd stock price is INR ₹24.45. On the other hand, Piramal Pharma Ltd stock price is INR ₹195.05.

How do dividend payouts of Mono Pharmacare Ltd and Piramal Pharma Ltd compare?

To compare the dividend payouts of Mono Pharmacare Ltd and Piramal Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions